Dynavax Technologies Corporation (DVAX) - Stock Prices, Stock Peers & Analysis

Home
DVAX

Company Name	Dynavax Technologies Corporation
Symbol	DVAX
Currency	USD
Price	11.61
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,519,656,120
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	10.23 - 15.15
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Ryan Spencer
Website	https://www.dynavax.com

An error occurred while fetching data.

About Dynavax Technologies Corporation

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.